Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder that affects the cilia, the tiny hair-like structures that line the airways, ears, and other parts of the body. These cilia play a crucial role in moving mucus and other materials out of the airways, ears, and sinuses. When they are dysfunctional due to genetic mutations, such as those in the CCDC65 gene, it can lead to a specific form of the disorder known as Primary Ciliary Dyskinesia Type 27. Understanding the symptoms of this condition is vital for early diagnosis and treatment. DNA Labs UAE offers a comprehensive genetic test for this condition, which is a crucial step in managing the disorder effectively.
Symptoms of CCDC65 Gene Primary Ciliary Dyskinesia Type 27
Primary Ciliary Dyskinesia Type 27, caused by mutations in the CCDC65 gene, leads to several symptoms that are key indicators of the disorder. These symptoms often appear in early childhood, although they can sometimes be present at birth. Recognizing these symptoms early on is crucial for effective management and treatment of the condition.
- Respiratory Issues: One of the most common symptoms includes chronic respiratory infections such as bronchitis and pneumonia. These infections are recurrent and can lead to further complications if not properly managed.
- Sinusitis and Otitis Media: Frequent sinus infections and middle ear infections (otitis media) are also prevalent among individuals with this condition. These can result in hearing problems and other complications if left untreated.
- Situs Inversus: Approximately 50% of individuals with PCD may have situs inversus, a condition where the major visceral organs are mirrored from their normal positions.
- Infertility: The dysfunction of cilia can also affect the reproductive system, potentially leading to infertility issues in affected individuals.
Genetic Testing for CCDC65 Gene Primary Ciliary Dyskinesia Type 27
Genetic testing plays a pivotal role in the diagnosis of Primary Ciliary Dyskinesia Type 27. DNA Labs UAE offers a comprehensive genetic test specifically designed to detect mutations in the CCDC65 gene. This test is crucial for confirming the diagnosis, which can then guide appropriate treatment and management strategies. Early diagnosis through genetic testing can significantly improve the quality of life for individuals with this condition.
Cost of the Genetic Test
The cost of the CCDC65 Gene Primary Ciliary Dyskinesia Type 27 genetic test at DNA Labs UAE is 4400 AED. This investment is essential for individuals who exhibit symptoms of the disorder or have a family history of PCD. The test provides valuable insights that can lead to a tailored treatment plan, significantly impacting the individual’s health and well-being.
Conclusion
Primary Ciliary Dyskinesia Type 27 is a challenging condition that affects various aspects of an individual’s health. Recognizing the symptoms early and opting for genetic testing can lead to a more manageable life with the condition. DNA Labs UAE is at the forefront of providing comprehensive genetic testing services, including the CCDC65 Gene Primary Ciliary Dyskinesia Type 27 genetic test. For more information and to schedule a test, visit DNA Labs UAE.
